Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2(+) T cells compared with the aminobisphosphonate drug zoledronic acid

Vδ2(+) T cells can recognize malignantly transformed cells as well as those infected with mycobacteria. This cross-reactivity supports the idea of using mycobacteria to manipulate Vδ2(+) T cells in cancer immunotherapy. To date, therapeutic interventions using Vδ2(+) T cells in cancer have involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenn, J, Ridgley, L A, White, A, Sarfas, C, Dennis, M, Dalgleish, A, Reljic, R, Sharpe, S, Bodman-Smith, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Cancer Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226146/
https://www.ncbi.nlm.nih.gov/pubmed/35404420
http://dx.doi.org/10.1093/cei/uxac032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226146/
https://www.ncbi.nlm.nih.gov/pubmed/35404420
http://dx.doi.org/10.1093/cei/uxac032

Ejemplares similares